Citadel Advisors
BFRI icon

Citadel Advisors’s Biofrontera BFRI Stock Holding History

Citadel Advisors’s Portfolio BFRI Stock Details BFRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$99.2K Buy
+104,941
New +$104K ﹤0.01% 12706
2025
Q2 		– Sell
-28,224
Closed -$22.6K – 12583
2025
Q1 		$22.6K Buy
+28,224
New +$29K ﹤0.01% 13058
2022
Q2 		– Sell
-2,525
Closed -$168K – 12882
2022
Q1 		$168K Buy
+2,525
New +$183K ﹤0.01% 11724

Other funds holding BFRI

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Citadel Advisors's BFRI Position: Q2 2026 in Review

Citadel Advisors opened a new position in Biofrontera (BFRI) in Q2 2026: 104,941 shares worth $99.2K. The stake represents ﹤0.01% of the portfolio and ranks #12706 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in BFRI as recently as Q1 2025.

Citadel Advisors first reported a position in BFRI in Q1 2022 and has held it in 3 quarters since. The position peaked at $168K in Q1 2022. 19 funds tracked by Wall St. Rank hold BFRI as of Q2 2026.

  • Citadel Advisors held 104,941 shares of Biofrontera worth $99.2K as of Q2 2026.
  • Biofrontera was a new Citadel Advisors position in Q2 2026.
  • Biofrontera made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12706 holding.
  • Citadel Advisors first reported a position in Biofrontera in Q1 2022 and has held it in 3 quarters since.
  • Citadel Advisors's Biofrontera position peaked at $168K in Q1 2022.
  • 19 funds tracked by Wall St. Rank held Biofrontera as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.